Clinical Trials Browser

Phase 2 × amivantamab × Head & Neck × Clear all

NCT05074940 2025-04-10

Amivantamab in Adenoid Cystic Carcinoma

Phase 2 Active not recruiting

Carcinoma, Adenoid Cystic, Salivary Gland Neoplasms